1. Home
  2. NCA vs EOLS Comparison

NCA vs EOLS Comparison

Compare NCA & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Municipal Value Fund

NCA

Nuveen California Municipal Value Fund

HOLD

Current Price

$9.52

Market Cap

315.0M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.84

Market Cap

304.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCA
EOLS
Founded
1987
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.0M
304.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NCA
EOLS
Price
$9.52
$4.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
64.7K
1.3M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
3.92%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$14.41
Revenue Next Year
N/A
$16.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$8.22
$4.09
52 Week High
$9.80
$13.66

Technical Indicators

Market Signals
Indicator
NCA
EOLS
Relative Strength Index (RSI) 53.32 48.13
Support Level $9.17 $4.74
Resistance Level $9.58 $4.99
Average True Range (ATR) 0.16 0.36
MACD 0.01 0.02
Stochastic Oscillator 61.76 33.95

Price Performance

Historical Comparison
NCA
EOLS

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: